Chronic ataxic neuropathy, ophthalmoplegia, immunoglobulin M paraprotein, cold agglutinins, and disialosyl antibodies presenting after COVID19 mRNA vaccination
Authors:
- 5 November 2024
- journal article
- letter
- Published by Wiley in Muscle & Nerve
- Vol. 71 (1) , 124-125
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United StatesJAMA Network Open, 2023
- CANOMAD unmasked by COVID‐19 in a man with Waldenström's macroglobulinaemiaeJHaem, 2021
- CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell–targeted therapiesBlood, 2020
- Canomad: report of a case with a 40‐year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade?Muscle & Nerve, 2013
- The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodiesBrain, 2001